MEAGHAN DESCHER: Open Payments
NPI 1538322912 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 38 payments from 12 companies in 2025. Trend: 2023 $768 · 2024 $1,216 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $199 |
| ABBVIE INC. | 4 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $73 |
| Boston Scientific Corporation | 3 | $68 |
| PFIZER INC. | 3 | $51 |
| Nalu Medical, Inc. | 2 | $48 |
| Abbott Laboratories | 2 | $37 |
| MML US, Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Medtronic, Inc. | 1 | $23 |
Products named: XTAMPZA, JOURNAVX, NURTEC ODT, Nalu Neurostimulation System, Intracept, QULIPTA, OCTRODE, UBRELVY.
Industry payments across PA — which companies pay providers there.
